Assyro AI

Orange Book product · Generic (ANDA)

ERYZOLE

ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

Generic (ANDA)ANDA 062758DISCN ALRA

At a glance

Jun 15, 1988

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 15, 1988

    38 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

Strength

EQ 200MG BASE/5ML;EQ 600MG BASE/5ML

Dosage form

GRANULE

Route

ORAL

TE code

Not listed

Application

ANDA 062758

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.